▶ 調査レポート

放射線治療の世界市場2022-2031:産業分析、規模、シェア、成長、動向、予測

• 英文タイトル:Radiation Therapy Market (Type: External Beam Radiation Therapy and Internal Radiation Therapy) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2022-2031

Transparency Market Researchが調査・発行した産業分析レポートです。放射線治療の世界市場2022-2031:産業分析、規模、シェア、成長、動向、予測 / Radiation Therapy Market (Type: External Beam Radiation Therapy and Internal Radiation Therapy) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2022-2031 / MRC2207A096資料のイメージです。• レポートコード:MRC2207A096
• 出版社/出版日:Transparency Market Research / 2022年5月
• レポート形態:英文、PDF、183ページ
• 納品方法:Eメール
• 産業分類:医療
• 販売価格(消費税別)
  Single User¥764,940 (USD5,795)▷ お問い合わせ
  Multi User¥1,160,940 (USD8,795)▷ お問い合わせ
  Corporate License¥1,556,940 (USD11,795)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
トランスペアレンシー・マーケット・リサーチ社の本調査レポートでは、世界の放射線治療市場について総合的に調査・分析し、序論、仮定・調査手法、エグゼクティブサマリー、市場概要、市場見通し、種類別(外部照射放射線治療、内部照射放射線治療)分析、エンドユーザー別分析、地域別(北米、ヨーロッパ、アジア太平洋、中南米、中東・アフリカ)分析、競争状況などの内容をまとめております。なお、本書に掲載されている企業情報にはElekta AB、Varian Medical Systems、IBA Radiopharma Solutions、Accuray Incorporated、Isoray, Inc.、Mevion Medical Systems、Hitachi, Ltd.、ViewRay, Inc.、Panacea Medical Technologies Pvt. Ltd.などが含まれています。
・序論
・仮定・調査手法
・エグゼクティブサマリー
・市場概要
・市場見通し
・世界の放射線治療市場規模:種類別(外部照射放射線治療、内部照射放射線治療)
・世界の放射線治療市場規模:エンドユーザー別
・世界の放射線治療市場規模:地域別(北米、ヨーロッパ、アジア太平洋、中南米、中東・アフリカ)
・競争状況

Radiation Therapy Market – Scope of Report

TMR’s report on the global radiation therapy market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2022 to 2031. The report provides revenue of the global radiation therapy market for the period 2017–2031, considering 2021 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global radiation therapy market from 2022 to 2031.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players’ product literature, annual reports, press releases, and relevant documents to understand the radiation therapy market.

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global radiation therapy market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report sheds light on the changing competitive dynamics in the global radiation therapy market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global radiation therapy market.

The report delves into the competitive landscape of the global radiation therapy market. Key players operating in the global radiation therapy market have been identified and each one of these has been profiled, in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are attributes of players in the global radiation therapy market profiled in this report.

RESEARCH METHODOLOGY

The research methodology will be a combination of exhaustive primary and secondary research to analyze the market radiation therapy.

Secondary Research

Secondary research includes a search of company literature, technical writing, patent data, Internet sources, and statistical data from government websites, trade associations, and agencies. This has proven to be the most reliable, effective, and successful approach for obtaining precise data, capturing industry participants’ insights, and recognizing business opportunities.

Secondary research sources that we typically refer, but are not limited to:

Company websites, presentations, annual reports, white papers, technical paper, product brochure
Internal and external proprietary databases and relevant patents
National government documents, statistical databases, and market reports
News articles, press releases, and webcasts specific to companies operating in the market

Specific Secondary Sources:

Industry Sources:
WorldWideScience.org
Elsevier, Inc.
National Institutes of Health (NIH)
PubMed
NCBI
Department of Health Care Service
Trade Data Sources
Trade Map
UN Comtrade
Trade Atlas
Company Information
OneSource Business Browser
Hoover’s
Factiva
Bloomberg
Mergers & Acquisitions
Thomson Mergers & Acquisitions
MergerStat
Profound

Primary Research

During the course of research, we conduct in-depth interviews and discussions with a wide range of key industry participants and opinion leaders. Primary research represents bulk of research efforts, supplemented by extensive secondary research.

We conduct primary interviews on the ongoing basis with industry participants and commentators to validate data and analysis. A typical research interview fulfills the following functions:

Provides first-hand information on market size, market trends, growth trends, competitive landscape, outlook, etc.
Helps in validating and strengthening secondary research findings
Further develops the analysis team’s expertise and market understanding
Primary research involves e-mail interactions, telephonic interviews, as well as face-to-face interviews for each market, category, segment, and sub-segment across geographies

Participants who typically take part in such a process include, but are not limited to:

Industry participants: Marketing/product managers, market intelligence managers, and regional sales managers
Purchasing/Sourcing managers, technical personnel, distributors
Outside experts: Investment bankers, valuation experts, and research analysts specializing in specific markets
Key opinion leaders specializing in different areas corresponding to different industry verticals

List of primary participants, but not limited to:

Advanced Oncotherapy PLC
Danfysik A/S
Hitachi, Ltd.
IBA Worldwide
Mevion Medical Systems, Inc.

Data Triangulation: Information culled from “Secondary & Primary Sources” is cross-checked with “TMR Knowledge Repository”, which is updated every quarter.

Market Estimation: Market size estimations involved in-depth study of product features, technology updates, geographic presence, product demand, sales data (value or volume), historical year-on-year growth, and others. Other approaches were also utilized to derive market size and forecasts. Where no hard data was available, we employed modeling techniques in order to produce comprehensive datasets. A rigorous methodology has been adopted, wherein the available hard data are cross-referenced with the following data types to produce estimates:

Demographic Data: Healthcare expenditure, inflation rates, and others
Industry Indicators: R&D investment, technology stage, and infrastructure, sector growth, and facilities

Market Forecasting: Market forecasts for various segments are derived taking into account drivers, restraints/challenges, and opportunities prevailing in the market and considering advantages/disadvantages of segments/sub-segments over other segments/sub-segments. Business environment, historical sales pattern, unmet needs, competitive intensity, and country-wise surgery data are some of the other pivotal factors, which are considered to derive market forecasts.

レポート目次

1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Radiation Therapy Market
4. Market Overview
4.1. Introduction
4.1.1. Therapy Type Definition
4.1.2. Industry Evolution / Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Radiation Therapy Market Analysis and Forecast, 2017-2031
4.4.1. Market Revenue Projections (US$ Mn)
5. Market Outlook
5.1. Healthcare Industry Overview
6. Global Radiation Therapy Market Analysis and Forecast, by Type
6.1. Introduction & Definition
6.2. Key Findings / Developments
6.3. Market Value Forecast, by Type, 2017-2031
6.3.1. External Beam Radiation Therapy
6.3.1.1. Conformal Radiation Therapy
6.3.1.2. Proton Beam Therapy
6.3.1.3. Image-guided Radiation Therapy
6.3.1.4. Stereotactic Radiation Therapy
6.3.1.5. Others
6.3.2. Internal Radiation Therapy
6.3.2.1. Brachytherapy
6.3.2.2. Systemic Radiation Therapy
6.4. Market Attractiveness Analysis, by Type
7. Global Radiation Therapy Market Analysis and Forecast, by End-user
7.1. Introduction & Definition
7.2. Key Findings / Developments
7.3. Market Value Forecast, by End-user, 2017-2031
7.3.1. Hospitals
7.3.2. Specialty Clinics
7.3.3. Others
7.4. Market Attractiveness Analysis, by End-user
8. Global Radiation Therapy Market Analysis and Forecast, by Region
8.1. Key Findings
8.2. Market Value Forecast, by Region
8.2.1. North America
8.2.2. Europe
8.2.3. Asia Pacific
8.2.4. Latin America
8.2.5. Middle East & Africa
8.3. Market Attractiveness Analysis, by Region
9. North America Radiation Therapy Market Analysis and Forecast
9.1. Introduction
9.1.1. Key Findings
9.2. Market Value Forecast, by Type, 2017-2031
9.2.1. External Beam Radiation Therapy
9.2.1.1. Conformal Radiation Therapy
9.2.1.2. Proton Beam Therapy
9.2.1.3. Image-guided Radiation Therapy
9.2.1.4. Stereotactic Radiation Therapy
9.2.1.5. Others
9.2.2. Internal Radiation Therapy
9.2.2.1. Brachytherapy
9.2.2.2. Systemic Radiation Therapy
9.3. Market Value Forecast, by End-user, 2017-2031
9.3.1. Hospitals
9.3.2. Specialty Clinics
9.3.3. Others
9.4. Market Value Forecast, by Country, 2017-2031
9.4.1. U.S.
9.4.2. Canada
9.5. Market Attractiveness Analysis
9.5.1. By Type
9.5.2. By End-user
9.5.3. By Country
10. Europe Radiation Therapy Market Analysis and Forecast
10.1. Introduction
10.1.1. Key Findings
10.2. Market Value Forecast, by Type, 2017-2031
10.2.1. External Beam Radiation Therapy
10.2.1.1. Conformal Radiation Therapy
10.2.1.2. Proton Beam Therapy
10.2.1.3. Image-guided Radiation Therapy
10.2.1.4. Stereotactic Radiation Therapy
10.2.1.5. Others
10.2.2. Internal Radiation Therapy
10.2.2.1. Brachytherapy
10.2.2.2. Systemic Radiation Therapy
10.3. Market Value Forecast, by End-user, 2017-2031
10.3.1. Hospitals
10.3.2. Specialty Clinics
10.3.3. Others
10.4. Market Value Forecast, by Country/Sub-region, 2017-2031
10.4.1. Germany
10.4.2. U.K.
10.4.3. France
10.4.4. Spain
10.4.5. Italy
10.4.6. Rest of Europe
10.5. Market Attractiveness Analysis
10.5.1. By Type
10.5.2. By End-user
10.5.3. By Country/Sub-region
11. Asia Pacific Radiation Therapy Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. Market Value Forecast, by Type, 2017-2031
11.2.1. External Beam Radiation Therapy
11.2.1.1. Conformal Radiation Therapy
11.2.1.2. Proton Beam Therapy
11.2.1.3. Image-guided Radiation Therapy
11.2.1.4. Stereotactic Radiation Therapy
11.2.1.5. Others
11.2.2. Internal Radiation Therapy
11.2.2.1. Brachytherapy
11.2.2.2. Systemic Radiation Therapy
11.3. Market Value Forecast, by End-user, 2017-2031
11.3.1. Hospitals
11.3.2. Specialty Clinics
11.3.3. Others
11.4. Market Value Forecast, by Country/Sub-region, 2017-2031
11.4.1. China
11.4.2. Japan
11.4.3. India
11.4.4. Australia & New Zealand
11.4.5. Rest of Asia Pacific
11.5. Market Attractiveness Analysis
11.5.1. By Type
11.5.2. By End-user
11.5.3. By Country/Sub-region
12. Latin America Radiation Therapy Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Market Value Forecast, by Type, 2017-2031
12.2.1. External Beam Radiation Therapy
12.2.1.1. Conformal Radiation Therapy
12.2.1.2. Proton Beam Therapy
12.2.1.3. Image-guided Radiation Therapy
12.2.1.4. Stereotactic Radiation Therapy
12.2.1.5. Others
12.2.2. Internal Radiation Therapy
12.2.2.1. Brachytherapy
12.2.2.2. Systemic Radiation Therapy
12.3. Market Value Forecast, by End-user, 2017-2031
12.3.1. Hospitals
12.3.2. Specialty Clinics
12.3.3. Others
12.4. Market Value Forecast, by Country/Sub-region, 2017-2031
12.4.1. Brazil
12.4.2. Mexico
12.4.3. Rest of Latin America
12.5. Market Attractiveness Analysis
12.5.1. By Type
12.5.2. By End-user
12.5.3. By Country/Sub-region
13. Middle East & Africa Radiation Therapy Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Market Value Forecast, by Type, 2017-2031
13.2.1. External Beam Radiation Therapy
13.2.1.1. Conformal Radiation Therapy
13.2.1.2. Proton Beam Therapy
13.2.1.3. Image-guided Radiation Therapy
13.2.1.4. Stereotactic Radiation Therapy
13.2.1.5. Others
13.2.2. Internal Radiation Therapy
13.2.2.1. Brachytherapy
13.2.2.2. Systemic Radiation Therapy
13.3. Market Value Forecast, by End-user, 2017-2031
13.3.1. Hospitals
13.3.2. Specialty Clinics
13.3.3. Others
13.4. Market Value Forecast, by Country/Sub-region, 2017-2031
13.4.1. GCC Countries
13.4.2. South Africa
13.4.3. Rest of Middle East & Africa
13.5. Market Attractiveness Analysis
13.5.1. By Type
13.5.2. By End-user
13.5.3. By Country/Sub-region
14. Competition Landscape
14.1. Market Player – Competition Matrix (by tier and size of companies)
14.2. Market Share Analysis, by Company, 2021
14.3. Company Profiles
14.3.1. Elekta AB
14.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.1.2. Financial Overview
14.3.1.3. Product Portfolio
14.3.1.4. SWOT Analysis
14.3.1.5. Strategic Overview
14.3.2. Varian Medical Systems
14.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.2.2. Financial Overview
14.3.2.3. Product Portfolio
14.3.2.4. SWOT Analysis
14.3.2.5. Strategic Overview
14.3.3. IBA Radiopharma Solutions
14.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.3.2. Financial Overview
14.3.3.3. Product Portfolio
14.3.3.4. SWOT Analysis
14.3.3.5. Strategic Overview
14.3.4. Accuray Incorporated
14.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.4.2. Financial Overview
14.3.4.3. Product Portfolio
14.3.4.4. SWOT Analysis
14.3.4.5. Strategic Overview
14.3.5. Isoray, Inc.
14.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.5.2. Financial Overview
14.3.5.3. Product Portfolio
14.3.5.4. SWOT Analysis
14.3.5.5. Strategic Overview
14.3.6. Mevion Medical Systems
14.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.6.2. Financial Overview
14.3.6.3. Product Portfolio
14.3.6.4. SWOT Analysis
14.3.6.5. Strategic Overview
14.3.7. Hitachi, Ltd.
14.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.7.2. Financial Overview
14.3.7.3. Product Portfolio
14.3.7.4. SWOT Analysis
14.3.7.5. Strategic Overview
14.3.8. ViewRay, Inc.
14.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.8.2. Financial Overview
14.3.8.3. Product Portfolio
14.3.8.4. SWOT Analysis
14.3.8.5. Strategic Overview
14.3.9. Panacea Medical Technologies Pvt. Ltd.
14.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.9.2. Financial Overview
14.3.9.3. Product Portfolio
14.3.9.4. SWOT Analysis
14.3.9.5. Strategic Overview

List of Tables
Table 01: Global Radiation Therapy Market Size (US$ Mn) Forecast, by Type, 2017-2031
Table 02: Global Radiation Therapy Market Size (US$ Mn) Forecast, by External Beam Radiation Therapy, 2017-2031
Table 03: Global Radiation Therapy Market Size (US$ Mn) Forecast, by Internal Radiation Therapy, 2017-2031
Table 04: Global Radiation Therapy Market Size (US$ Mn) Forecast, by End-user, 2017-2031
Table 05: Global Radiation Therapy Market Size (US$ Mn) Forecast, by Region, 2017-2031
Table 06: North America Radiation Therapy Market Size Value (US$ Mn) Forecast, by Country, 2016–2018
Table 07: North America Radiation Therapy Market Size (US$ Mn) Forecast, by Type, 2017-2031
Table 08: North America Radiation Therapy Market Size (US$ Mn) Forecast, by External Beam Radiation Therapy, 2017-2031
Table 09: North America Radiation Therapy Market Size (US$ Mn) Forecast, by Internal Radiation Therapy, 2017-2031
Table 10: North America Radiation Therapy Market Size (US$ Mn) Forecast, by End-user, 2017-2031
Table 11: Europe Radiation Therapy Market Size Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
Table 12: Europe Radiation Therapy Market Size (US$ Mn) Forecast, by Type, 2017-2031
Table 13: Europe Radiation Therapy Market Size (US$ Mn) Forecast, by External Beam Radiation Therapy, 2017-2031
Table 14: Europe Radiation Therapy Market Size (US$ Mn) Forecast, by Internal Radiation Therapy, 2017-2031
Table 15: Europe Radiation Therapy Market Size (US$ Mn) Forecast, by End-user, 2017-2031
Table 16: Asia Pacific Radiation Therapy Market Size Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
Table 17: Asia Pacific Radiation Therapy Market Size (US$ Mn) Forecast, by Type, 2017-2031
Table 18: Asia Pacific Radiation Therapy Market Size (US$ Mn) Forecast, by External Beam Radiation Therapy, 2017-2031
Table 19: Asia Pacific Radiation Therapy Market Size (US$ Mn) Forecast, by Internal Radiation Therapy, 2017-2031
Table 20: Asia Pacific Radiation Therapy Market Size (US$ Mn) Forecast, by End-user, 2017-2031
Table 21: Latin America Radiation Therapy Market Size Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
Table 22: Latin America Radiation Therapy Market Size (US$ Mn) Forecast, by Type, 2017-2031
Table 23: Latin America Radiation Therapy Market Size (US$ Mn) Forecast, by External Beam Radiation Therapy, 2017-2031
Table 24: Latin America Radiation Therapy Market Size (US$ Mn) Forecast, by Internal Radiation Therapy, 2017-2031
Table 25: Latin America Radiation Therapy Market Size (US$ Mn) Forecast, by End-user, 2017-2031
Table 26: Middle East & Africa Radiation Therapy Market Size Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
Table 27: Middle East & Africa Radiation Therapy Market Size (US$ Mn) Forecast, by Type, 2017-2031
Table 28: Middle East & Africa Radiation Therapy Market Size (US$ Mn) Forecast, by External Beam Radiation Therapy, 2017-2031
Table 29: Middle East & Africa Radiation Therapy Market Size (US$ Mn) Forecast, by Internal Radiation Therapy, 2017-2031
Table 30: Middle East & Africa Radiation Therapy Market Size (US$ Mn) Forecast, by End-user, 2017-2031